Instrumentarium gets FDA OK on breast system

Article

The FDA gave Instrumentarium Imaging 510(k) clearance to market its Delta 32 3-D breast imaging system and digital stereotactic system. The system provides 3-D and layered viewing for assessment of biopsy depth and wire localization placement.The newly

The FDA gave Instrumentarium Imaging 510(k) clearance to market its Delta 32 3-D breast imaging system and digital stereotactic system. The system provides 3-D and layered viewing for assessment of biopsy depth and wire localization placement.

The newly approved items are part of Instrumentarium's Diamond Breast Care System. The stereotactic feature can image from any two angles, which gives it flexibility and saves procedure time. Although the system is film-based, an amorphous selenium full-field digital upgrade kit is in the works. n

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.